MEDICINA
Saila
Fred Hutchinson Cancer Research Center
Seattle, Estados UnidosFred Hutchinson Cancer Research Center-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2023
-
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
The Lancet Oncology, Vol. 24, Núm. 9, pp. 1029-1041
2011
2010
-
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Nature Genetics, Vol. 42, Núm. 5, pp. 426-429